Meng Mei
Directeur/Membre du Conseil chez SINOVAC BIOTECH LTD.
Provenance du réseau au premier degré de Meng Mei
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Beijing Paratera Tech Corp. Ltd.
 Beijing Paratera Tech Corp. Ltd. Packaged SoftwareTechnology Services Beijing PARATERA Tech Corp., Ltd. engages in the provision of supercomputing cloud services and computing power operation services. Its services include parallel general supercomputing cloud, parallel industry cloud, and parallel AI cloud. The company was founded on February 15, 2007 and is headquartered in Beijing, China.
14
| Public Company | Packaged Software | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Meng Mei via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Sinovac Biotech Co. Ltd.
 Sinovac Biotech Co. Ltd. Pharmaceuticals: MajorHealth Technology Sinovac Biotech Co., Ltd. is a biotechnology company engaged in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza and SARS. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
| China Agricultural University | College/University | Undergraduate Degree Graduate Degree | |
| Vlerick Leuven Gent Management School | College/University | Masters Business Admin | |
| INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd.
 Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. Investment ManagersFinance Part of Blackstone, Inc., Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. is a Chinese company that provides investment management services. The private company is based in Shime Yi, China. | Investment Managers | Corporate Officer/Principal | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Chairman | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
The Blackstone Group
 The Blackstone Group Investment ManagersFinance Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The private company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform. | Investment Managers | Corporate Officer/Principal | |
| CHINA ANIMAL HEALTHCARE LTD. | Pharmaceuticals: Major | Director/Board Member | |
| University of Colorado Denver Business School | College/University | Undergraduate Degree | |
| The University of Reading | College/University | Undergraduate Degree | |
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Director/Board Member | |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
 dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
| Research Grants Council | Corporate Officer/Principal | ||
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Industry & Technology Development Council | Director/Board Member | ||
| The Hong Kong University of Science & Technology | College/University | Corporate Officer/Principal | |
| Santai Biotechnology Research Institute Co. Ltd. | President | ||
| Hongsen Investment Management Ltd. | Corporate Officer/Principal | ||
| Applied Research Council | Director/Board Member | ||
| Hk Bio-Med Innotech Association | Founder | ||
| Lo & Associates | Chairman | ||
| The University of Waterloo | College/University | Undergraduate Degree | |
| NEW FRONTIER HEALTH CORPORATION | Hospital/Nursing Management | Director/Board Member | |
SHEP Technologies, Inc.
 SHEP Technologies, Inc. Internet Software/ServicesTechnology Services Shep Technologies, Inc. is engaged in the development and pre-commercialization of the SHEP System. The SHEP System is designed to improve fuel economy and vehicle performance by capturing kinetic energy generated from braking. The company was founded on July 7, 1992 and is headquartered in Vancouver, Canada. | Internet Software/Services | Director of Finance/CFO | |
| LUYE PHARMA GROUP LTD. | Pharmaceuticals: Major | Director/Board Member | |
China Investment (Tianjin) Thermal Power Co., Ltd.
 China Investment (Tianjin) Thermal Power Co., Ltd. Miscellaneous ManufacturingProducer Manufacturing China Investment (Tianjin) Thermal Power Co., Ltd. engages in the research, development, production, and sales of smart and energy-saving pipes, and supporting fittings; as well as the operation, development, and construction of smart heating. The company was founded on August 16, 2010 and is headquartered in Tianjin, China. | Miscellaneous Manufacturing | Director/Board Member | |
HP China Holding BV
 HP China Holding BV MiscellaneousMiscellaneous Part of HP, Inc., HP China Holding BV functions as an investment holding Dutch company and provides financial services. | Miscellaneous | Private Equity Investor | |
| PEKING UNIVERSITY RESOURCES (HOLDINGS) COMPANY LIMITED | Packaged Software | Chief Executive Officer | |
Asia America MultiTechnology Association
 Asia America MultiTechnology Association Miscellaneous Commercial ServicesCommercial Services Asia America MultiTechnology Association (AAMA) is the largest pan-technology association in the world. The private company is based in Menlo Park, CA and has subsidiaries in China. The company builds a bridge for technology and entrepreneurship in Asia and America. | Miscellaneous Commercial Services | Founder | |
| ShangGu Capital | Chairman | ||
Hbcc Investment
 Hbcc Investment Investment ManagersFinance HBCC Investment (HBCC Investment) is a venture capital firm founded in 2017. The firm is headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
| Tsinghua University | College/University | Graduate Degree | |
| CAPITALONLINE DATA SERVICE CO., LTD. | Data Processing Services | Director/Board Member | |
| University of Science & Technology Beijing | College/University | Doctorate Degree | |
Beijing Health Guard Biotechnology, Inc.
 Beijing Health Guard Biotechnology, Inc. BiotechnologyHealth Technology Beijing Health Guard Biotechnology, Inc. engages in the research, development, and industrialization of recombinant protein vaccines. It is involved in the development of HPV vaccines and multiple innovative candidate vaccines for other infectious diseases, such as a recombinant bivalent COVID-19 vaccine, a recombinant polyvalent nor virus vaccine, a recombinant RSV vaccine, and a recombinant zoster vaccine. The company was founded by Xiao Jiang Chen, Run Lin Ma and Yong Jiang Liu on April 14, 2008 and is headquartered in Beijing, China. | Biotechnology | Director/Board Member | |
| BEIJING JCZ TECHNOLOGY CO.,LTD. | Electronic Components | Director/Board Member | |
| Central University of Finance & Economics | College/University | Undergraduate Degree | |
Esco Lifesciences Group Ltd.
 Esco Lifesciences Group Ltd. Miscellaneous Commercial ServicesCommercial Services Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
| AEOLUS TYRE CO., LTD. | Automotive Aftermarket | Director/Board Member | |
| Beijing Virus Society | Corporate Officer/Principal | ||
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Anhui University | College/University | Undergraduate Degree | |
| BEYONDSOFT CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| National Development & Reform Commission | General Government | Corporate Officer/Principal | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| GENETRON HOLDINGS LIMITED | Medical/Nursing Services | Director/Board Member | |
| State Economic & Trade Commission | Corporate Officer/Principal |
Statistiques
Internationale
| Chine | 26 |
| Hong Kong | 12 |
| Etats-Unis | 6 |
| Îles Cayman | 3 |
| Canada | 3 |
Sectorielle
| Consumer Services | 12 |
| Health Technology | 11 |
| Commercial Services | 6 |
| Finance | 5 |
| Technology Services | 4 |
Opérationnelle
| Director/Board Member | 56 |
| Corporate Officer/Principal | 31 |
| Director of Finance/CFO | 19 |
| Independent Dir/Board Member | 19 |
| Chairman | 13 |
Relations les plus connectées
| Insiders | |
|---|---|
| Simon Anderson | 27 |
| Yuk Lam Lo | 23 |
| Shan Fu | 17 |
| Jian Li | 10 |
| Wei Dong Yin | 7 |
| Ricky Lei | 7 |
| Helen G. Yang | 6 |
| Xiao Jing Li | 5 |
| Nan Wang | 5 |
| Qiang Gao | 4 |
| Ming Xia | 3 |
| Wei Min Zheng | 3 |
| Xiao Hua Fan | 2 |
| Xiao Mei Yin | 2 |
| Bing Zhou | 2 |
